Aramune Technologies Limited
Ashley Cooper is an experienced leader in the biomedical and technology sectors, currently serving as the Chief Executive Officer of Aramune Technologies Limited since December 2020, where a focus on reducing antimicrobial overuse in livestock through microbiome enhancement and plant phytochemical extraction is emphasized. In addition to leading Aramune, Ashley has been the Managing Director of Cooper Ventures Limited since August 2007, providing consultancy services to emerging biomedical and med-tech companies. Previous executive roles include CEO positions at AlternOx Scientific Ltd, Inventa Therapeutics, Celsius Health Ltd, Pertinax Pharma Limited, Cotton Mouton Diagnostics Limited, and Placentum Limited, as well as Managing Director of Neuronostics Limited. Ashley has a proven track record in fostering business development, strategic financing, and management within the healthcare industry.
This person is not in any teams
Aramune Technologies Limited
Aramune Technologies is developing natural, plant derived feed materials which can be mixed with standard animal feeds to replace antimicrobial agents and promote growth.